Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2016

01-08-2016 | Case Report

Histological features of mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver: a case report and literature review

Authors: Hiroto Nishino, Etsuro Hatano, Satoru Seo, Shinsuke Shibuya, Takayuki Anazawa, Taku Iida, Toshihiko Masui, Kojiro Taura, Hironori Haga, Shinji Uemoto

Published in: Clinical Journal of Gastroenterology | Issue 4/2016

Login to get access

Abstract

Primary hepatic neuroendocrine carcinoma (NEC) is rare, and its origin, clinical features, diagnosis and treatment have not been clarified. Primary mixed NEC and hepatocellular carcinoma (HCC) is even rarer and is divided into either combined type or collision type. We report a patient with the combined type of mixed NEC and HCC. A 72-year-old male was diagnosed with HCC and underwent hepatectomy because of the presence of two tumors in his liver. Histological examination demonstrated that one of the tumors had both NEC and HCC components. The transitional zone was noted in the immunohistological examination, and the tumor was determined to be the combined type of primary mixed NEC and HCC. This was the first description of an HCC component being found in an NEC-dominant area in a primary mixed NEC and HCC tumor. Three weeks after hepatectomy, an abdominal computed tomography scan showed extensive regional and para-aortic lymphadenopathy, and early relapse was suspected in the patient. The patient died 3 months after the operation despite treatment with combination chemotherapy. This report describes an unfavorable case and summarizes all the primary mixed NEC and HCC tumor cases that have been previously reported.
Literature
1.
go back to reference Pilichowska M, Kimura N, Ouchi A, et al. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases. Pathol Int. 1999;49:318–24.CrossRefPubMed Pilichowska M, Kimura N, Ouchi A, et al. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases. Pathol Int. 1999;49:318–24.CrossRefPubMed
2.
go back to reference Kaya G, Pasche C, Osterheld MC, et al. Primary neuroendocrine carcinoma of the liver: an autopsy case. Pathol Int. 2001;51:874–8.CrossRefPubMed Kaya G, Pasche C, Osterheld MC, et al. Primary neuroendocrine carcinoma of the liver: an autopsy case. Pathol Int. 2001;51:874–8.CrossRefPubMed
3.
go back to reference Yasuda E, Takeshita A, Murata S, et al. Neuroendocrine carcinoma of the liver associated with dermatomyositis: autopsy case and review of the literature. Pathol Int. 2006;56:749–54.CrossRefPubMed Yasuda E, Takeshita A, Murata S, et al. Neuroendocrine carcinoma of the liver associated with dermatomyositis: autopsy case and review of the literature. Pathol Int. 2006;56:749–54.CrossRefPubMed
4.
go back to reference Yang CS, Wen MC, Jan YJ, et al. Combined primary neuroendocrine carcinoma and hepatocellular carcinoma of the liver. J Chin Med Assoc. 2009;72:430–3.CrossRefPubMed Yang CS, Wen MC, Jan YJ, et al. Combined primary neuroendocrine carcinoma and hepatocellular carcinoma of the liver. J Chin Med Assoc. 2009;72:430–3.CrossRefPubMed
5.
go back to reference Yamaguchi R, Nakashima O, Ogata T, et al. Hepatocellular carcinoma with an unusual neuroendocrine component. Pathol Int. 2004;54:861–5.CrossRefPubMed Yamaguchi R, Nakashima O, Ogata T, et al. Hepatocellular carcinoma with an unusual neuroendocrine component. Pathol Int. 2004;54:861–5.CrossRefPubMed
6.
go back to reference Ishida M, Seki K, Tatsuzawa A, et al. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case. Surg Today. 2003;33:214–8.CrossRefPubMed Ishida M, Seki K, Tatsuzawa A, et al. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case. Surg Today. 2003;33:214–8.CrossRefPubMed
7.
go back to reference Barsky SH, Linnoila I, Triche TJ, et al. Hepatocellular carcinoma with carcinoid features. Hum Pathol. 1984;15:892–4.CrossRefPubMed Barsky SH, Linnoila I, Triche TJ, et al. Hepatocellular carcinoma with carcinoid features. Hum Pathol. 1984;15:892–4.CrossRefPubMed
8.
go back to reference Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–93.CrossRefPubMed Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–93.CrossRefPubMed
9.
go back to reference Gurung A, Yoshida EM, Scudamore CH, et al. Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: case report and concise review. Ann Hepatol. 2012;11:715–20.PubMed Gurung A, Yoshida EM, Scudamore CH, et al. Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: case report and concise review. Ann Hepatol. 2012;11:715–20.PubMed
11.
go back to reference Akahoshi T, Higashi H, Tsuruta S, et al. Primary neuroendocrine carcinoma coexisting with hemangioma in the liver: report of a case. Surg Today. 2010;40:185–9.CrossRefPubMed Akahoshi T, Higashi H, Tsuruta S, et al. Primary neuroendocrine carcinoma coexisting with hemangioma in the liver: report of a case. Surg Today. 2010;40:185–9.CrossRefPubMed
12.
go back to reference Edmondson HA. Tumors of the liver and intrahepatic bile duct. In: Fascicle 25, editor. Atlas of tumor pathology. Washington: Armed Forces Institute of Pathology; 1958. p. 19–29. Edmondson HA. Tumors of the liver and intrahepatic bile duct. In: Fascicle 25, editor. Atlas of tumor pathology. Washington: Armed Forces Institute of Pathology; 1958. p. 19–29.
13.
go back to reference Huang YQ, Xu F, Yang JM, et al. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases. Hepatobiliary Pancreat Dis Int. 2010;9:44–8.PubMed Huang YQ, Xu F, Yang JM, et al. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases. Hepatobiliary Pancreat Dis Int. 2010;9:44–8.PubMed
14.
go back to reference Yang K, Cheng YS, Yang JJ, et al. Primary hepatic neuroendocrine tumor with multiple liver metastases: a case report with review of the literature. World J Gastroenterol. 2015;21:3132–8.CrossRefPubMedPubMedCentral Yang K, Cheng YS, Yang JJ, et al. Primary hepatic neuroendocrine tumor with multiple liver metastases: a case report with review of the literature. World J Gastroenterol. 2015;21:3132–8.CrossRefPubMedPubMedCentral
15.
go back to reference Breeman W, de Blois E, Sze Chan H, et al. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives. Semin Nucl Med. 2011;41:314–21.CrossRefPubMed Breeman W, de Blois E, Sze Chan H, et al. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives. Semin Nucl Med. 2011;41:314–21.CrossRefPubMed
16.
go back to reference Buchmann I, Henze M, Engelbrecht S, et al. Comparison of 68 Ga-DOTATOC PET and 111In-DTPAOC(Octreoscan)SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2007;34:1617–26.CrossRefPubMed Buchmann I, Henze M, Engelbrecht S, et al. Comparison of 68 Ga-DOTATOC PET and 111In-DTPAOC(Octreoscan)SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2007;34:1617–26.CrossRefPubMed
17.
go back to reference Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010. p. 13–4. Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010. p. 13–4.
18.
go back to reference Kano Y, Kakinuma S, Goto F, et al. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule. Clin J Gastroenterol. 2014;7:449–54.CrossRefPubMed Kano Y, Kakinuma S, Goto F, et al. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule. Clin J Gastroenterol. 2014;7:449–54.CrossRefPubMed
19.
go back to reference Sotiropoulos GC, Charalampoudis P, Delladetsima I, et al. Surgery for giant primary neuroendocrine carcinoma of the liver. J Gastrointest Surg. 2014;18:839–41.CrossRefPubMed Sotiropoulos GC, Charalampoudis P, Delladetsima I, et al. Surgery for giant primary neuroendocrine carcinoma of the liver. J Gastrointest Surg. 2014;18:839–41.CrossRefPubMed
20.
go back to reference Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol. 2003;10:1171–5.CrossRefPubMed Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol. 2003;10:1171–5.CrossRefPubMed
21.
go back to reference Mima K, Beppu T, Murata A, et al. Primary neuroendocrine tumor in the liver treated by hepatectomy: report of a case. Surg Today. 2011;41:1655–60.CrossRefPubMed Mima K, Beppu T, Murata A, et al. Primary neuroendocrine tumor in the liver treated by hepatectomy: report of a case. Surg Today. 2011;41:1655–60.CrossRefPubMed
22.
go back to reference Dong M, Phan AT, Yao JC. New strategies for advanced neuroendocrine tumors in the era of targeted therapy. Clin Cancer Res. 2012;18:1830–6.CrossRefPubMed Dong M, Phan AT, Yao JC. New strategies for advanced neuroendocrine tumors in the era of targeted therapy. Clin Cancer Res. 2012;18:1830–6.CrossRefPubMed
24.
go back to reference Garcia MT, Bejarano PA, Yssa M, et al. Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature. Virchows Arch. 2006;449:376–81.CrossRefPubMed Garcia MT, Bejarano PA, Yssa M, et al. Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature. Virchows Arch. 2006;449:376–81.CrossRefPubMed
25.
go back to reference Nakanishi C, Sato K, Ito Y, et al. Combined hepatocellular carcinoma and neuroendocrine carcinoma with sarcomatous change of the liver after transarterial chemoembolization. Hepatol Res. 2012;42:1141–5.CrossRefPubMed Nakanishi C, Sato K, Ito Y, et al. Combined hepatocellular carcinoma and neuroendocrine carcinoma with sarcomatous change of the liver after transarterial chemoembolization. Hepatol Res. 2012;42:1141–5.CrossRefPubMed
26.
go back to reference Artopoulos JG, Destuni C. Primary mixed hepatocellular carcinoma with carcinoid characteristics. A case report. Hepatogastroenterology. 1994;41:442–4.PubMed Artopoulos JG, Destuni C. Primary mixed hepatocellular carcinoma with carcinoid characteristics. A case report. Hepatogastroenterology. 1994;41:442–4.PubMed
27.
go back to reference Tazi EM, Essadi I, M’rabti H, et al. Hepatocellular carcinoma and high grade neuroendocrine carcinoma: a case report and review of the literature. World J Oncol. 2011;2:37–40. Tazi EM, Essadi I, M’rabti H, et al. Hepatocellular carcinoma and high grade neuroendocrine carcinoma: a case report and review of the literature. World J Oncol. 2011;2:37–40.
28.
go back to reference Aboelenen A, El-Hawary AK, Megahed N, et al. Right hepatectomy for combined primary neuroendocrine and hepatocellular carcinoma. A case report. Int J Surg Case Rep. 2014;5:26–9.CrossRefPubMed Aboelenen A, El-Hawary AK, Megahed N, et al. Right hepatectomy for combined primary neuroendocrine and hepatocellular carcinoma. A case report. Int J Surg Case Rep. 2014;5:26–9.CrossRefPubMed
29.
go back to reference Sorbye H, Welin S, Langer SW, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol. 2013;24:152–60.CrossRefPubMed Sorbye H, Welin S, Langer SW, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol. 2013;24:152–60.CrossRefPubMed
30.
go back to reference Strosberg J, Coppola D, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas. 2010;39:799–800.CrossRefPubMedPubMedCentral Strosberg J, Coppola D, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas. 2010;39:799–800.CrossRefPubMedPubMedCentral
Metadata
Title
Histological features of mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver: a case report and literature review
Authors
Hiroto Nishino
Etsuro Hatano
Satoru Seo
Shinsuke Shibuya
Takayuki Anazawa
Taku Iida
Toshihiko Masui
Kojiro Taura
Hironori Haga
Shinji Uemoto
Publication date
01-08-2016
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2016
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-016-0669-0

Other articles of this Issue 4/2016

Clinical Journal of Gastroenterology 4/2016 Go to the issue